Philip Mirowski talk: The infirmity of open science in pharmaceutical research

Loading Events
This event has passed.

Rather than the panacea for the ills of science in the 21st century, open science is a Trojan Horse for reinforcing the neoliberal commercialisation of science; thus argues prominent historian and philosopher Philip Mirowski. In this event, he presents further evidence from the pharmaceuticals sector to support this thesis and demonstrate how the program is failing.

A panel discussion chaired by UCL Institute for Innovation and Public Purpose (IIPP) Director Mariana Mazzucato will follow, featuring Jack Stilgoe (UCL Department of Science and Technology Studies) and Matthew Todd (Open Source Pharma and UCL School of Pharmacy).

Leave a Message, Comment or Review